Lucia Seminario Vidal
Dermatology · Tampa, FLNPI 1588912869
Payments from drug & device makers
Across 525 payments — averaging $3751.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$848K
- Novartis$693K
- Eli Lilly$129K
- Boehringer Ingelheim$129K
- E.r. Squibb & Sons, L.L.C.$55K
- Kyowa Kirin, Inc.$47K
- plus $69K from 12 others
Across 42 payments — averaging $1493.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glenmark Pharmaceuticals Inc., USA$33K
- Eli Lilly$13K
- Ichnos Glenmark Innovation Inc$12K
- Novartis$5K
What the payments were for
- Consulting fees$27,09449%
- Speaking & faculty fees$24,00743%
- Travel & lodging$3,0876%
- Food & beverage$1,2002%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 419 | $848,123 |
| Novartis | 20 | $692,814 |
| Eli Lilly | 9 | $129,280 |
| Boehringer Ingelheim | 16 | $128,749 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54,991 |
| Kyowa Kirin, Inc. | 25 | $46,778 |
| Pfizer | 7 | $29,618 |
| Amgen | 5 | $19,886 |
| Helsinn Therapeutics (U.S.), Inc. | 8 | $7,749 |
| Boehringer Ingelheim International GmbH | 4 | $3,271 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $3,158 |
| Regeneron Healthcare Solutions, Inc. | 1 | $2,480 |
| Blueprint Medicines Corporation | 1 | $2,258 |
| Genentech USA, Inc. | 1 | $139 |
| AbbVie | 1 | $102 |
| Sun Pharmaceutical Industries Inc. | 1 | $60 |
| Mallinckrodt Enterprises LLC | 2 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,969,515 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 24 | $1,023 |
| Mupirocin | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Luis MenendezTampa$923K
- James GrichnikTampa$743K
- Michael SherlingLake Worth$78.9M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Eduardo WeissHollywood$5.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.